Label: information for the user
Protopic 0.1% ointment
tacrolimus monohydrate
Read this label carefully before starting to use the medication, as it contains important information for you.
Label content
1.What Protopic is and for what it is used
2.What you need to know before starting to use Protopic
3.How to use Protopic
4.Possible adverse effects
5.Storage of Protopic
6.Contents of the package and additional information
The active ingredient of Protopic, tacrolimus monohydrate, is an immunomodulator agent.
Protopic 0.1% ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who do not respond adequately or are intolerant to conventional therapies such as topical corticosteroids.
Once moderate to severe atopic dermatitis disappears or almost disappears after up to 6 weeks of treatment of a flare-up, and if you experience frequent flares (i.e., 4 or more per year), you can prevent them from recurring or prolong the time free of flares by using Protopic 0.1% ointment twice a week.
In atopic dermatitis, excessive skin reaction of the immune system causes skin inflammation (pruritus, redness, dryness). Protopic modifies the abnormal immune response and relieves skin inflammation and pruritus.
Do not use Protopic
Warnings and precautions
Consult your doctor before starting to use Protopic:
Children
Other medications, cosmetics, and Protopic
Inform your doctor or pharmacist if you areusingor haveused, have been able to userecently or may have to use any other medication.
You can use moisturizing creams and lotions during treatment with Protopic, but not during the two hours before and after applying Protopic.
The use of Protopic at the same time as other topical preparations or simultaneously with oral immunosuppressive medications (such as corticosteroids) has not been studied.
Use of Protopic with alcohol
While using Protopic, consuming alcohol may cause redness or inflammation of the skin or face and a sensation of heat.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist beforeusing thismedication.
Protopic contains butylhydroxytoluene (E321)
Protopic contains butylhydroxytoluene (E321), which may cause local skin reactions (such as contact dermatitis) or irritation of the eyes and mucous membranes.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Adults (16 years of age and older)
Two concentrations of Protopic (Protopic 0.03% and Protopic 0.1% ointment) are available for adult patients (16 years of age and older). Your doctor will decide which concentration is most suitable for you.
Typically, treatment with Protopic 0.1% ointment is initiated twice a day, once in the morning and once at night, until the eczema has cleared up. Your doctor will decide if the frequency of application can be reduced depending on your eczema response or if the lower concentration Protopic 0.03% ointment can be used.
Treat each affected skin area until the eczema has cleared up. Improvement is usually seen within a week. If you do not notice any improvement after two weeks, consult your doctor for other possible treatments.
Your doctor may tell you to use Protopic 0.1% ointment twice a week once your atopic dermatitis has cleared up or almost cleared up. Protopic 0.1% ointment should be applied once a day, twice a week (e.g., Monday and Thursday), to the areas of your body that are usually affected by atopic dermatitis. There should be 2-3 days without treatment with Protopic between applications.
If symptoms reappear, use Protopic twice a day, as indicated above, and visit your doctor to review your treatment.
If you accidentally ingest something of the ointment
If someone accidentally ingests the ointment, consult your doctor or pharmacist as soon as possible. Do not try to induce vomiting.
If you forgot to use Protopic
If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication mayproduceadverse effects, although not all people will experience them.
Very frequent (may affect more than 1 in 10 people):
These symptoms are usually mild or moderate and generally disappear within a week of using Protopic.
Frequent (may affect up to 1 in 10 people):
Rare (may affect fewer than 1 in 100 people):
After treatment twice a week, skin infections at the application site have been reported in adults.
Also reported have been rosacea (facial redness), rosacea-type dermatitis, lentigo (flat brown skin patches), edema at the application site, and herpes eye infections during post-marketing surveillance.
Reporting Adverse Effects
If you experienceany type of adverse effect, consult your doctor or pharmacist, even if it is apossibleadverse effect not listed in this prospectus.You can also report them directly through thenational notification system included in theAppendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication afterthe expiration date that appears on the packaging and on the boxafter EXP. The expiration date is the last day of the month indicated.
Do not store above25°C.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. By doing so, you will help protect the environment.
Composition of Protopic
One gram of Protopic 0.1% ointment contains 1.0mg of tacrolimus (as tacrolimus monohydrate).
Appearance of the product and contents of the package
Protopic is a white or slightly yellowish ointment. It is available in tubes with 10, 30, or60grams of ointment.Only some package sizes may be commercially available.Protopic is available in two concentrations (Protopic 0.03% and Protopic 0.1% ointment).
Marketing Authorization Holder
LEO Pharma A/S
Industriparken 55
2750 Ballerup
Denmark
Responsible for manufacturing
Astellas Ireland Co. Ltd.
Killorglin
County Kerry
Ireland
LEO Laboratories Ltd.
285 Cashel Road
Crumlin, Dublin 12
Ireland
For more information about this medication, please contact the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien LEO Pharma N.V./S.A Tel: +32 3 740 7868 | Lithuania Biocodex UAB Tel: +370 37 408 681 |
Bulgaria Borola Ltd Phone: +359 2 9156 136 | Luxembourg/Luxemburg LEO Pharma N.V./S.A Tel: +323 740 7868 |
Czech Republic LEO Pharma s.r.o. Tel: +420 225 992 272 | Hungary LEO Pharma Tel: +36 1 888 0525 |
Denmark LEO Pharma AB Tel: +45 70 22 49 11 | Malta E.J. Busuttil Ltd Tel: +356 2144 7184 |
Germany LEO Pharma GmbH Tel: +49 6102 2010 | Netherlands LEO Pharma B.V. Tel: +31 205104141 |
Estonia Biocodex OÜ Tel: +372 6 056 014 | Norway LEO Pharma AS Tel: +47 22514900 |
Greece LEO Pharmaceutical Hellas S.A. Phone: +30 210 68 34322 | Austria LEO Pharma GmbH Tel: +43 1 503 6979 |
Spain Laboratorios LEO Pharma, S.A. Tel: +34 93 221 3366 | Poland LEO Pharma Sp. z o.o. Tel: +48 22 244 18 40 |
France Laboratoires LEO SA Tel: +33 1 3014 40 00 | Portugal LEO Farmacêuticos Lda. Tel: +351 21 711 0760 |
Croatia Remedia d.o.o. Tel: +3851 3778 770 | Romania LEO Pharma A/S Romania Tel: +40 213121963 |
Ireland LEO Laboratories Ltd Tel: +353 1 490 8924 | Slovenia PHARMAGAN d.o.o. Tel: +386 4 2366 700 |
Iceland Vistor hf. Phone: +354 535 7000 | Slovakia LEO Pharma s.r.o. Tel: +421 2 5939 6236 |
Italy LEO Pharma S.p.A. Tel: +39 06 52625500 | Finland/Suomi LEO Pharma Oy Phone: +358 20 721 8440 |
Cyprus The Star Medicines Importers Co. Ltd. Phone: +357 2537 1056 | Sweden LEO Pharma AB Tel: +46 40 3522 00 |
Lithuania Biocodex SIA Tel: +371 6761 9365 | United Kingdom LEO Laboratories Ltd Tel: +44 1844 347333 |
Last review date of this leaflet:
The detailed information about this medication is available on the website of the European Medicines Agencyhttp://www.ema.europa.eu.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.